MedPath
HSA Approval

VASITIMB TABLETS 10mg/20mg

SIN17039P

VASITIMB TABLETS 10mg/20mg

VASITIMB TABLETS 10mg/20mg

July 3, 2024

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C10BA02

Manufacturer Information

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Krka, d.d., Novo mesto

Active Ingredients

Ezetimibe

10.00mg

Ezetimibe

Simvastatin

20.00mg

Simvastatin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VASITIMB TABLETS 10mg/20mg - HSA Approval | MedPath